Sale!

NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the NHP2 gene that are associated with Dyskeratosis Congenita (DC), specifically the autosomal recessive type 2 variant of the disease. DC is a rare, genetically inherited disorder characterized by the premature aging of cells and tissues, leading to symptoms such as skin abnormalities, nail dystrophy, and bone marrow failure. The test plays a critical role in the early detection and management of the condition, allowing for timely intervention and genetic counseling. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED, reflecting the comprehensive analysis and precision involved in diagnosing this complex condition.

Description

NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test

Test Name: NHP2 Gene Dyskeratosis Congenita Autosomal Recessive Type 2 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for NHP2 Gene Dyskeratosis Congenita, Autosomal Recessive Type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NHP2 Gene Dyskeratosis Congenita, Autosomal Recessive Type 2 NGS Genetic DNA Test gene NHP2

Test Details: The NHP2 gene is associated with a genetic disorder called dyskeratosis congenita, autosomal recessive type 2. Dyskeratosis congenita is a rare inherited disorder that affects multiple body systems, including the skin, nails, and bone marrow. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of dyskeratosis congenita, NGS genetic testing can be used to identify mutations or variations in the NHP2 gene that are associated with the condition. By identifying these genetic variations, NGS genetic testing can help confirm a diagnosis of dyskeratosis congenita, autosomal recessive type 2. It can also be used to provide information about the specific mutation(s) present in an individual, which can be helpful for genetic counseling and family planning. It’s important to note that NGS genetic testing may not be available in all healthcare settings, and the specific genes included in the test may vary depending on the laboratory performing the analysis. Therefore, it’s recommended to consult with a healthcare professional or genetic counselor to determine the most appropriate genetic testing options for a particular individual.

Test Name	NHP2 Gene Dyskeratosis congenita autosomal recessive type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for NHP2 Gene Dyskeratosis congenita, autosomal recessive type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NHP2 Gene Dyskeratosis congenita, autosomal recessive type 2 NGS Genetic DNA Test gene NHP2
Test Details	The NHP2 gene is associated with a genetic disorder called dyskeratosis congenita, autosomal recessive type 2. Dyskeratosis congenita is a rare inherited disorder that affects multiple body systems, including the skin, nails, and bone marrow. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of dyskeratosis congenita, NGS genetic testing can be used to identify mutations or variations in the NHP2 gene that are associated with the condition. By identifying these genetic variations, NGS genetic testing can help confirm a diagnosis of dyskeratosis congenita, autosomal recessive type 2. It can also be used to provide information about the specific mutation(s) present in an individual, which can be helpful for genetic counseling and family planning. It’s important to note that NGS genetic testing may not be available in all healthcare settings, and the specific genes included in the test may vary depending on the laboratory performing the analysis. Therefore, it’s recommended to consult with a healthcare professional or genetic counselor to determine the most appropriate genetic testing options for a particular individual.